Ad Header



The Pulse of the Pharmaceutical Industry

Supreme Court rejects Covidien bid to restore patent verdict against Ethicon

Written by: | | Dated: Monday, November 30th, 2015


In refusing to hear the case, the high court left in place a December 2014 ruling by the U.S. Court of Appeals for the Federal Circuit that threw out a judge’s finding that Ethicon had infringed upon Covidien’s patents for surgical cutting tools. Covidien is owned by Medtronic Plc.

In a separate patent case, the court declined to hear Biolitec AG’s challenge to a $70 million contempt finding relating to a patent dispute the company had with AngioDynamics Inc.

The court’s refusal to take the case means a March ruling by the 1st U.S. Circuit Court of Appeals in favor of AngioDynamics remains intact.


(Reporting by Lawrence Hurley; Editing by Will Dunham)

Source: Reuters Health

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!


Ad Right Bottom

Main Navigation